Strides gets USFDA nod for anti-allergic drug

Strides Pharma Science on Thursday said it has received approval from the US health regulator for Loratadine Softgel Capsules, a medication typically used to treat allergies.

In a filing to BSE Strides said its "step-down wholly-owned subsidiary, Strides Pharma Global Pte Ltd, Singapore, has received approval for Loratadine Softgel Capsules, 10 mg (OTC) from the United States Food & Drug Administration (USFDA)."